Showing results (51-60 of 434) with videos related to

Sort By:
Pageof 44
Neoplasia (New York, N.Y.)|August 10, 2000
The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterationsP Hausner, D J Venzon, L Grogan, et al.
Cancer Treatment Reports|April 1, 1979
Current concepts in immunoregulatory T-cell neoplasmsS Broder, T Uchiyama, T A Waldmann
The Journal of Clinical Investigation|August 1, 1986
Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virusR Yarchoan, R R Redfield, S Broder
American Journal of Clinical Pathology|October 1, 1979
Neoplasms of immunoregulatory cellsS Broder, T Uchiyama, T A Waldmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virusJ M Pluda, R Yarchoan, S Broder
Journal of Medicinal Chemistry|July 1, 1988
1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virusT R Webb, H Mitsuya, S Broder
The EMBO Journal|November 1, 1992
The SCL gene product: a positive regulator of erythroid differentiationP D Aplan, K Nakahara, S H Orkin, et al.
Molecular and Cellular Biology|January 1, 1988
Complex translocation disrupts c-myc regulation in a human plasma cell myelomaG F Hollis, A F Gazdar, V Bertness, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1991
Targeted therapy of human immunodeficiency virus-related diseaseH Mitsuya, R Yarchoan, S Kageyama, et al.
Archives of Internal Medicine|January 1, 1982
Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patientsE Gelmann, T Anderson, E Jaffe, et al.
Pageof 44